Caroline Speers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Caroline Speers has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
- Sharlene Gill
BC Cancer, Vancouver, BC V5Z 4E6, Canada
35 shared publications - Carl James Brown
St Paul's Hospital, Vancouver, BC, Canada
33 shared publications - Heather C. Stuart
Division of General Surgery, BC Cancer Agency, Vancouver, BC V5Z 4E6, Canada
33 shared publications - Jonathan M. Loree
BC Cancer, Vancouver, BC, Canada
33 shared publications - Arif A. Arif
University of British Columbia Department of Medicine Vancouver, BC V5Z1M9
32 shared publications - Fergal Donellan
Division of Gastroenterology, University of British Columbia, Vancouver, BC V6T1Z4, Canada
32 shared publications
Latest Publications
- 23 August 2025
- Published by Elsevier in Clinical Oncology
- Vol. 47, 103928
A Nomogram to Estimate Locoregional Recurrence-Free Survival for Women With T1-2 N0 Breast Cancer Managed With or Without Postmastectomy Radiotherapy
- 23 August 2025
- Published by Elsevier in Clinical Oncology
- Vol. 47, 103928
A Nomogram to Estimate Locoregional Recurrence-Free Survival for Women With T1-2 N0 Breast Cancer Managed With or Without Postmastectomy Radiotherapy
- Open Access
- 6 April 2023
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 6 from Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer
Supplemental Figure 6. Disease-specific disease-free survival (DSDFS) for early-stage rectal cancer receiving neoadjuvant short-course radiotherapy with non-colorectal deaths censored (DSDFS).
- 6 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 6 from Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer
Supplemental Figure 6. Disease-specific disease-free survival (DSDFS) for early-stage rectal cancer receiving neoadjuvant short-course radiotherapy with non-colorectal deaths censored (DSDFS).
- Open Access
- 6 April 2023
- Published by American Association for Cancer Research (AACR)
Supplemental Table 1 from Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer
Supplemental Table 1 – Characteristics and treatment response in rectal cancers treated with neoadjuvant therapy.
- 6 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 1 from Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer
Supplemental Table 1 – Characteristics and treatment response in rectal cancers treated with neoadjuvant therapy.
- Open Access
- 6 April 2023
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 5 from Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer
Supplemental Figure 5. Overall survival, disease-specific survival and disease-free survival by age group and treatment type in early-stage rectal cancers.
- 6 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 5 from Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer
Supplemental Figure 5. Overall survival, disease-specific survival and disease-free survival by age group and treatment type in early-stage rectal cancers.
- Open Access
- 6 April 2023
- Published by American Association for Cancer Research (AACR)
Supplemental Table 1 from Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer
Supplemental Table 1 – Characteristics and treatment response in rectal cancers treated with neoadjuvant therapy.
- 6 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 1 from Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer
Supplemental Table 1 – Characteristics and treatment response in rectal cancers treated with neoadjuvant therapy.
- Open Access
- 6 April 2023
- Published by American Association for Cancer Research (AACR)
Data from Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer
Preoperative radiotherapy for early-stage rectal cancer has risks and benefits that may impact treatment choice in young patients. We reviewed radiotherapy use and outcomes for rectal cancer by age. Patients with early-stage rectal cancer in the Canadian province of British Columbia from 2002 to 2016 were identified (n = 6,232). Baseline characteristics, treatment response, overall survival (OS), disease-free survival (DFS), disease-specific survival (DSS), and locoregional recurrence rate (LRR) were compared between patients <50 (early-onset; n = 532) and ≥50 years old (average-onset; n = 5,700). Early-onset patients were more likely to receive preoperative chemoradiotherapy than short-course radiotherapy [OR, 2.20; 95% confidence interval (CI), 1.67–2.89; P < 0.0001], but also had higher nodal (P = 0.00096) and overall clinical staging (P = 0.033). Cancer downstaging and pathologic complete response rates were similar in those receiving neoadjuvant chemoradiotherapy by age. Early-onset and average-onset patients had similar DSS (P = 0.91) and DFS (P = 0.27) in multivariate analysis unless non-colorectal deaths, which were higher in older patients, were censored in the DFS model (HR, 1.30; 95% CI, 1.01–1.68; P = 0.042). LRR also did not differ between age groups (P = 0.88). Outcomes did not differ based on radiotherapy type. Young patients with rectal cancer are more likely to present with higher staging and receive long-course chemoradiotherapy. DSS did not differ by age group; however, young patients had worse DFS when we censored competing risks of death in older patients.Significance:This population-based study suggests younger patients are more likely to receive chemoradiotherapy, potentially due to higher stage at diagnosis, and response is comparable by age.
- 6 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer
Preoperative radiotherapy for early-stage rectal cancer has risks and benefits that may impact treatment choice in young patients. We reviewed radiotherapy use and outcomes for rectal cancer by age. Patients with early-stage rectal cancer in the Canadian province of British Columbia from 2002 to 2016 were identified (n = 6,232). Baseline characteristics, treatment response, overall survival (OS), disease-free survival (DFS), disease-specific survival (DSS), and locoregional recurrence rate (LRR) were compared between patients <50 (early-onset; n = 532) and ≥50 years old (average-onset; n = 5,700). Early-onset patients were more likely to receive preoperative chemoradiotherapy than short-course radiotherapy [OR, 2.20; 95% confidence interval (CI), 1.67–2.89; P < 0.0001], but also had higher nodal (P = 0.00096) and overall clinical staging (P = 0.033). Cancer downstaging and pathologic complete response rates were similar in those receiving neoadjuvant chemoradiotherapy by age. Early-onset and average-onset patients had similar DSS (P = 0.91) and DFS (P = 0.27) in multivariate analysis unless non-colorectal deaths, which were higher in older patients, were censored in the DFS model (HR, 1.30; 95% CI, 1.01–1.68; P = 0.042). LRR also did not differ between age groups (P = 0.88). Outcomes did not differ based on radiotherapy type. Young patients with rectal cancer are more likely to present with higher staging and receive long-course chemoradiotherapy. DSS did not differ by age group; however, young patients had worse DFS when we censored competing risks of death in older patients.Significance:This population-based study suggests younger patients are more likely to receive chemoradiotherapy, potentially due to higher stage at diagnosis, and response is comparable by age.
- Open Access
- 6 April 2023
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 4 from Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer
Supplemental Figure 4. Disease-free survival (DFS) by age in early-stage rectal cancers. The Kaplan-Meier survival curves are shown for a period of 10 years. The survival curves begin to separate towards the end of the routine follow-up period of 5 years.
- 6 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 4 from Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer
Supplemental Figure 4. Disease-free survival (DFS) by age in early-stage rectal cancers. The Kaplan-Meier survival curves are shown for a period of 10 years. The survival curves begin to separate towards the end of the routine follow-up period of 5 years.
- Open Access
- 6 April 2023
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 1 from Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer
Supplemental Figure 1. Consort diagram showing patient inclusion at each stage of analysis. Patient groups used in each stage of analysis are adjacent to the indicated analyses. Patients excluded at each stage of analysis are also indicated.
- 6 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 1 from Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer
Supplemental Figure 1. Consort diagram showing patient inclusion at each stage of analysis. Patient groups used in each stage of analysis are adjacent to the indicated analyses. Patients excluded at each stage of analysis are also indicated.
- Open Access
- 6 April 2023
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 2 from Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer
Supplemental Figure 2. (A) Overall clinical stage and (B) overall pathological stage distribution stratified by age.
- 6 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 2 from Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer
Supplemental Figure 2. (A) Overall clinical stage and (B) overall pathological stage distribution stratified by age.
- Open Access
- 6 April 2023
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 3 from Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer
Supplemental Figure 3. Kaplan Meier curves for locoregional recurrence (LRR) in (A) early-onset and average-onset patients, (B) early-onset decile groups, and (C) early-onset and average-onset patients that received long-course chemoradiotherapy or (D) short-course radiotherapy.
- 6 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 3 from Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer
Supplemental Figure 3. Kaplan Meier curves for locoregional recurrence (LRR) in (A) early-onset and average-onset patients, (B) early-onset decile groups, and (C) early-onset and average-onset patients that received long-course chemoradiotherapy or (D) short-course radiotherapy.